Published • loading... • Updated
Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal
Summary by Eyewire+
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal
Key Takeaways Sun Pharma will acquire Organon in an all-cash deal valued at $11.75 billion, significantly expanding its global scale and product portfolio The combined company will strengthen its position in women’s health, branded generics, and biosimilars, while increasing its focus on innovative medicines The transaction, expected to close in early 2027, is projected to boost revenue, nearly double EBITDA and cash flow, and enhance long-ter…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
